People · Operator
Named in public records as an officer, director or promoter · active 2010–2018 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Attune Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $23.3M | $793.0M | 2018 |
| Thar Pharmaceuticals Inc | — | Pharmaceuticals | Series A | $15.9M | $42.5M | 2010 |
Jason Bablak at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jason Bablak on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Roderick Wong | 1 | 4 |
| Robert Roy | 1 | 3 |
| Lalit Chordia | 1 | 2 |
| Adam Tomasi | 1 | 2 |
| Raymond K. Houck | 1 | 2 |
| Ira Kalfus | 1 | 1 |
| Houck Raymond | 1 | 1 |
| Phillip Sussman | 1 | 1 |
| Lalit K. Chordia | 1 | 1 |
| Mazen K. Hanna | 1 | 1 |
| Ira K. Kalfus | 1 | 1 |
| Philip K. Sussman | 1 | 1 |
| Robert K. Roy | 1 | 1 |
| Jason K. Bablak | 1 | 1 |
| Brian K. Moyer | 1 | 1 |
| Filip Amram | 1 | 1 |
| Andrew McDonald | 1 | 1 |
| Raymond Houck | 1 | 1 |
| Philip Sussman | 1 | 1 |
| Mazen Hanna | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.